Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gadolinium Deposition Disease”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Very early researchWithdrawnNCT05359835
What this trial is testing

DTPA (Diethylenetriaminepenta-acetate) Chelation for Symptoms After Gadolinium-assisted MRI Exposure

Who this might be right for
Gadolinium Deposition Disease
Stanford University
Testing effectiveness (Phase 2)Ended earlyNCT02947022
What this trial is testing

Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease

Who this might be right for
HeadacheCognitive DisturbanceSkin Hyperpigmentation+1 more
University of North Carolina, Chapel Hill 1
Not applicableStudy completedNCT06269055
What this trial is testing

Long-term Result of DTPA (Diethylenetriamine Pentaacetate) Chelation for Gadolinium Deposition Disease

Who this might be right for
Gadolinium Deposition DiseaseCa-DTPA
Stanford University 30